HealthVerity real-world data supports CDC study on HIV PrEP surveillance
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
This is part three of a three-part series on the essential qualities of claims data for life...
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where...
Key benefits of real-world lab data for life sciences and pharma Real-world lab results enhance...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
Few areas of medicine have captured public interest over the past two years quite like glucagon-like peptide-1 (GLP-1) receptor agonists. Originally developed to improve glycemic control in type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and...